Pre-existing insulin autoantibodies predict efficacy of otelixizumab in preserving residual beta cell function in recent-onset type 1 diabetes

Onderzoeksoutput: Meeting abstract (Journal)

Originele taal-2English
Pagina's (van-tot)1-452
Aantal pagina's452
TijdschriftDiabetologia
Volume57
StatusPublished - 2014
Evenement50th EASD Annual Meeting - Vienna, Austria
Duur: 15 sep 201419 sep 2014

Citeer dit